H.B. Fuller Acquires AMS to Expand Medical Market Presence
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 25 2026
0mins
Source: Newsfilter
- Strategic Acquisition Opportunity: H.B. Fuller has made a cash offer of £2.85 per share to acquire AMS, valuing the transaction at £715 million, which is expected to significantly enhance the company's competitiveness in the medical market and drive EBITDA margins above 20%.
- Market Potential Expansion: This acquisition will increase H.B. Fuller’s Total Addressable Market (TAM) from $80 billion to $95 billion, covering surgical adhesives, tapes, and biosurgical products, and is projected to contribute an additional $300 million in annual revenues.
- Significant Synergies: H.B. Fuller anticipates capturing approximately $55 million in run-rate revenue and cost synergies by 2031, primarily through the elimination of public company costs and rationalization of overlapping expenses, thereby enhancing financial flexibility.
- Enhanced R&D Capabilities: With AMS's dedicated team of over 75 R&D personnel, combined with H.B. Fuller’s medical facilities in the U.S. and Italy, the acquisition is expected to accelerate new product launches and reduce execution risks, further driving the company’s expansion in the healthcare market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy FUL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on FUL
Wall Street analysts forecast FUL stock price to rise
4 Analyst Rating
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 57.570
Low
60.00
Averages
70.00
High
80.00
Current: 57.570
Low
60.00
Averages
70.00
High
80.00
About FUL
H.B. Fuller Company is a pureplay adhesives company. It operates as a formulator, manufacturer and marketer of adhesives, sealants and other specialty chemical products. Its Hygiene, Health and Consumable Adhesives segment manufactures and supplies adhesive products in the assembly, packaging, converting, nonwoven and hygiene, health and beauty, graphic arts and envelope markets. Its Engineering Adhesives segment produces and supplies industrial adhesives, such as reactive, light cure, two-part liquids, polyurethane, silicone, film and fast cure products. The Building Adhesive Solutions segment includes products used for the commercial roofing industry (pressure-sensitive adhesives, tapes and sealants) and heating, ventilation and air conditioning and insulation applications (duct sealants, weather barriers and fungicidal coatings and block fillers). It also includes caulks and sealants for the consumer market and professional trade, sold through retailers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
H.B. Fuller Exceeds Q2 Expectations with Strategic Focus on Medical Adhesives
- Earnings Beat: H.B. Fuller reported a 9% year-over-year increase in adjusted EBITDA to $181 million for Q2 2026, surpassing expectations and demonstrating strong execution amid global sourcing and rapid pricing strategies during supply disruptions.
- Revenue Growth: The company achieved revenues of $950.3 million, exceeding the Zacks Consensus Estimate of $926.9 million, resulting in a surprise rate of 2.5%, indicating effective strategic shifts towards medical adhesives.
- Record Cash Flow: Operating cash flow reached a record $121 million, with net debt to adjusted EBITDA improving to 3.1 times, reflecting robust financial management that supports future investments and acquisitions.
- Strategic Acquisition Plan: H.B. Fuller proposed an all-cash offer of 285 pence per share for Advanced Medical Solutions, which is expected to expand its medical adhesives platform more than fourfold and push combined medical business EBITDA margins above 30% by 2030.
See More
U.S. Stocks Close Lower on Friday, Chipmakers Weigh on Market
- Market Decline: The S&P 500 and Nasdaq 100 fell by 0.05% and 1.09% respectively on Friday, reaching two-week lows, indicating market sensitivity to the weak performance of chipmakers, which could undermine investor confidence.
- Chipmaker Sell-off: The significant drop in Samsung Electronics and SK Hynix shares led to a more than 5% decline in South Korea's Kospi Index, triggering a global downturn in semiconductor stocks and exacerbating market uncertainty.
- Oil Price Impact: WTI crude oil prices fell over 3% to a four-month low on Friday, which helps lower inflation expectations and supports the stock market, but also reflects potential slowdowns in global economic growth.
- Consumer Sentiment Revision: The University of Michigan's consumer sentiment index was revised upward by 0.6 to 49.5, although still below the expected 50.0, indicating a cautious consumer outlook that may affect future spending.
See More
H.B. Fuller Upgraded to Overweight by J.P. Morgan with $67 Price Target
- Upgraded Outlook: J.P. Morgan upgraded H.B. Fuller from Neutral to Overweight with a price target increase from $58 to $67, reflecting the company's ability to grow adjusted EBITDA through price increases and positive currency effects in a flat to declining volume environment.
- EBITDA Growth Insights: Analyst Jeffrey Zekauskas noted that H.B. Fuller's adjusted EBITDA for Q2 2026 increased by 9% due to a 3% price hike and a 3% positive currency effect, while H1 saw a 4% growth, demonstrating effective cost control and pricing strategies.
- Volume Forecast Adjustment: Although H.B. Fuller anticipates a 4%-6% decline in volume for H2, Zekauskas believes this estimate may be overly pessimistic, as the company claims that quarter-to-date volumes are flat and comparable to Q2 year-over-year rates, indicating potentially stable market demand.
- Cost Control Strategy: The company is downsizing its manufacturing footprint to cut costs, and the analyst suggests that lower oil prices and the opening of the Strait of Hormuz are likely to alleviate raw material cost pressures in 2027, further enhancing the company's profitability.
See More
US Stock Market Under Pressure as Chip Stocks Plummet
- Market Weakness: The S&P 500 and Nasdaq 100 indices fell by 0.07% and 0.75%, respectively, reaching two-week lows, indicating market sensitivity to the weak performance of chipmakers, which may lead to declining investor confidence.
- Chip Stock Plunge: The significant sell-off of Samsung Electronics and SK Hynix caused the South Korean Kospi index to drop over 5%, triggering a global decline in chip stocks and exacerbating market uncertainty.
- Oil Price Decline Impact: WTI crude oil prices fell by more than 3%, easing inflation expectations and supporting stocks; however, the recovery of crude exports to 75% of pre-war levels may influence future market dynamics.
- Consumer Sentiment Revision: The University of Michigan's consumer sentiment index was revised upward to 49.5, although still below the expected 50.0, reflecting cautious consumer attitudes towards the economic outlook, which could affect retail and consumer-related stocks.
See More
US Stocks Decline as Chipmakers Weigh on Market
- Market Decline: The S&P 500 index fell by 0.54% and the Nasdaq 100 dropped by 1.38%, both hitting two-week lows, indicating a weak market sentiment primarily driven by the poor performance of chipmakers, which significantly pressured the overall market.
- Chipmaker Sell-off: The sharp decline in Samsung Electronics and SK Hynix led to a more than 5% drop in South Korea's Kospi index, triggering a global sell-off in chip stocks and exacerbating investor concerns regarding the tech sector.
- Oil Price Impact: WTI crude oil prices fell by over 3% today, which not only eased inflation expectations but also lowered bond yields; however, the overall market remained under pressure due to weak stock performance.
- Software Stock Resilience: Despite the overall market downturn, software stocks like ServiceNow and Salesforce rose by over 6% and 4% respectively, somewhat limiting the market's downside, reflecting ongoing investor confidence in the software sector.
See More
Major Wall Street Rating Changes on Friday
- Diageo Upgrade: TD Cowen upgraded Diageo from hold to buy, citing valuation dislocation as an attractive entry point, with CEO-led cost cuts and reinvestment expected to restore growth and enhance commercial execution.
- James Hardie Initiation: Stephens initiated coverage of James Hardie with an overweight rating and a $31 price target, highlighting its status as a high-quality company and its position as the second-largest composite decking manufacturer following its merger with AZEK.
- Nike Downgrade: KeyBanc downgraded Nike from overweight to sector weight, indicating that the turnaround is taking longer than anticipated, with slight reductions in FY27 estimates reflecting higher-than-expected headwinds in China and EMEA.
- American Tower Upgrade: RBC upgraded American Tower from sector perform to outperform, noting superior organic revenue growth compared to peers, despite rising interest rate pressures, indicating strong market potential.
See More
H.B. Fuller Exceeds Q2 Expectations with Strategic Focus on Medical Adhesives
- Earnings Beat: H.B. Fuller reported a 9% year-over-year increase in adjusted EBITDA to $181 million for Q2 2026, surpassing expectations and demonstrating strong execution amid global sourcing and rapid pricing strategies during supply disruptions.
- Revenue Growth: The company achieved revenues of $950.3 million, exceeding the Zacks Consensus Estimate of $926.9 million, resulting in a surprise rate of 2.5%, indicating effective strategic shifts towards medical adhesives.
- Record Cash Flow: Operating cash flow reached a record $121 million, with net debt to adjusted EBITDA improving to 3.1 times, reflecting robust financial management that supports future investments and acquisitions.
- Strategic Acquisition Plan: H.B. Fuller proposed an all-cash offer of 285 pence per share for Advanced Medical Solutions, which is expected to expand its medical adhesives platform more than fourfold and push combined medical business EBITDA margins above 30% by 2030.
See More
U.S. Stocks Close Lower on Friday, Chipmakers Weigh on Market
- Market Decline: The S&P 500 and Nasdaq 100 fell by 0.05% and 1.09% respectively on Friday, reaching two-week lows, indicating market sensitivity to the weak performance of chipmakers, which could undermine investor confidence.
- Chipmaker Sell-off: The significant drop in Samsung Electronics and SK Hynix shares led to a more than 5% decline in South Korea's Kospi Index, triggering a global downturn in semiconductor stocks and exacerbating market uncertainty.
- Oil Price Impact: WTI crude oil prices fell over 3% to a four-month low on Friday, which helps lower inflation expectations and supports the stock market, but also reflects potential slowdowns in global economic growth.
- Consumer Sentiment Revision: The University of Michigan's consumer sentiment index was revised upward by 0.6 to 49.5, although still below the expected 50.0, indicating a cautious consumer outlook that may affect future spending.
See More
H.B. Fuller Upgraded to Overweight by J.P. Morgan with $67 Price Target
- Upgraded Outlook: J.P. Morgan upgraded H.B. Fuller from Neutral to Overweight with a price target increase from $58 to $67, reflecting the company's ability to grow adjusted EBITDA through price increases and positive currency effects in a flat to declining volume environment.
- EBITDA Growth Insights: Analyst Jeffrey Zekauskas noted that H.B. Fuller's adjusted EBITDA for Q2 2026 increased by 9% due to a 3% price hike and a 3% positive currency effect, while H1 saw a 4% growth, demonstrating effective cost control and pricing strategies.
- Volume Forecast Adjustment: Although H.B. Fuller anticipates a 4%-6% decline in volume for H2, Zekauskas believes this estimate may be overly pessimistic, as the company claims that quarter-to-date volumes are flat and comparable to Q2 year-over-year rates, indicating potentially stable market demand.
- Cost Control Strategy: The company is downsizing its manufacturing footprint to cut costs, and the analyst suggests that lower oil prices and the opening of the Strait of Hormuz are likely to alleviate raw material cost pressures in 2027, further enhancing the company's profitability.
See More
US Stock Market Under Pressure as Chip Stocks Plummet
- Market Weakness: The S&P 500 and Nasdaq 100 indices fell by 0.07% and 0.75%, respectively, reaching two-week lows, indicating market sensitivity to the weak performance of chipmakers, which may lead to declining investor confidence.
- Chip Stock Plunge: The significant sell-off of Samsung Electronics and SK Hynix caused the South Korean Kospi index to drop over 5%, triggering a global decline in chip stocks and exacerbating market uncertainty.
- Oil Price Decline Impact: WTI crude oil prices fell by more than 3%, easing inflation expectations and supporting stocks; however, the recovery of crude exports to 75% of pre-war levels may influence future market dynamics.
- Consumer Sentiment Revision: The University of Michigan's consumer sentiment index was revised upward to 49.5, although still below the expected 50.0, reflecting cautious consumer attitudes towards the economic outlook, which could affect retail and consumer-related stocks.
See More
US Stocks Decline as Chipmakers Weigh on Market
- Market Decline: The S&P 500 index fell by 0.54% and the Nasdaq 100 dropped by 1.38%, both hitting two-week lows, indicating a weak market sentiment primarily driven by the poor performance of chipmakers, which significantly pressured the overall market.
- Chipmaker Sell-off: The sharp decline in Samsung Electronics and SK Hynix led to a more than 5% drop in South Korea's Kospi index, triggering a global sell-off in chip stocks and exacerbating investor concerns regarding the tech sector.
- Oil Price Impact: WTI crude oil prices fell by over 3% today, which not only eased inflation expectations but also lowered bond yields; however, the overall market remained under pressure due to weak stock performance.
- Software Stock Resilience: Despite the overall market downturn, software stocks like ServiceNow and Salesforce rose by over 6% and 4% respectively, somewhat limiting the market's downside, reflecting ongoing investor confidence in the software sector.
See More
Major Wall Street Rating Changes on Friday
- Diageo Upgrade: TD Cowen upgraded Diageo from hold to buy, citing valuation dislocation as an attractive entry point, with CEO-led cost cuts and reinvestment expected to restore growth and enhance commercial execution.
- James Hardie Initiation: Stephens initiated coverage of James Hardie with an overweight rating and a $31 price target, highlighting its status as a high-quality company and its position as the second-largest composite decking manufacturer following its merger with AZEK.
- Nike Downgrade: KeyBanc downgraded Nike from overweight to sector weight, indicating that the turnaround is taking longer than anticipated, with slight reductions in FY27 estimates reflecting higher-than-expected headwinds in China and EMEA.
- American Tower Upgrade: RBC upgraded American Tower from sector perform to outperform, noting superior organic revenue growth compared to peers, despite rising interest rate pressures, indicating strong market potential.
See More
